注射用头孢硫脒致不良反应的文献分析
2018-06-13刘兴春李戒戎吴倪王芊入李波贺朝久
刘兴春 李戒戎 吴倪 王芊入 李波 贺朝久
【摘要】 目的:探讨注射用头孢硫脒致不良反应(ADR)的一般规律和特点。方法:检索《维普中文科技期刊数据库》(VIP)和《中国期刊全文数据库》(CNKI)2005-2016年注射用头孢硫脒所致不良反应文献,并进行统计、分析。结果:45~59岁年龄段发生率较高(35.29%);多在用药后30 min内发生;临床症状主要体现在皮肤及其附件损害、变态反应、呼吸系统损害,严重者可出现过敏性休克、多脏器多血等,死亡1例。结论:临床上应重视注射用头孢硫脒的不良反应,加强用药监测,防范不良反应发生,确保患者用药安全。
【关键词】 注射用头孢硫脒; 不良反应; 文献分析
doi:10.14033/j.cnki.cfmr.2018.4.090 文献标识码 A 文章编号 1674-6805(2018)04-0177-03
A Literature Analysis of Adverse Drug Reactions Induced by Cefathiamidine for Injection/LIU Xingchun,LI Jierong,WU Ni,et al.//Chinese and Foreign Medical Research,2018,16(4):177-179
【Abstract】 Objective:To study the characteristics and rules of adverse drug reaction(ADR) induced by Cefathiamidine for Injection.Method:The ADRs induced by Cefathiamidine for Injection reported in domestic medical journals during 2005 to 2016 were retrieved by means of VIP and CNKI,and related cases were collected for statistic analysis.Result:There were no significant gender differences in the 17 cases.Most of the ADRs appeared within 30 minutes after administration.The clinical manifestation of ADR was mainly reflected in the integumentary system,respiratory system and allergic reaction,severe cases were allergic shock and organ hemorrhage,1 case died.Conclusion:More attention should be paid to the ADRs of Cefathiamidine for Injectionin order to prevent adverse drug reactions and ensure safe medication.
【Key words】 Cefathiamidine for injection; Adverse drug reactions; Literature analysis
First-authors address:The Peoples Hospital of Pidu District in Chengdu City,Chengdu 611730,China
头孢硫脒是我国自行研制并首先上市的第一代头孢菌素,对革兰阳性菌和部分革兰阴性菌均有良好的抗菌活性。在临床上,该药物主要用于敏感菌引起的呼吸系统、肝胆系统、五官、泌尿系统的感染及心内膜炎、败血症,尤其适用于金黄色葡萄球菌、草绿色链球菌和肠球菌等革兰阳性球菌引起的各种中、重度感染[1]。2014年7月1日-2015年6月30日,国家药品不良反应(ADR)监测数据库中收到注射用头孢硫脒致不良反应报告5802例,严重不良反应报告277例,其中过敏性休克不良反应表现较为突出,占严重病例报告的17.0%[2]。本研究针对国内近年来应用注射用头孢硫脒出现不良反应的文献报道进行归纳分析,旨在为临床合理用药提供参考。
1 资料与方法
1.1 一般资料
以“头孢硫脒”和“不良反应”为关键词,通过《维普中文科技期刊数据库》《中国期刊全文数据库》查阅2005-2016年间国内报道的有关头孢硫脒致ADR的个案文献。……
